Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-084470
Filing Date
2013-11-14
Accepted
2013-11-14 08:14:25
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-22264_110q.htm 10-Q 597032
2 EX-31.1 a13-22264_1ex31d1.htm EX-31.1 11509
3 EX-31.2 a13-22264_1ex31d2.htm EX-31.2 11758
4 EX-32.1 a13-22264_1ex32d1.htm EX-32.1 7459
  Complete submission text file 0001104659-13-084470.txt   5614914

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT conx-20130930.xml EX-101.INS 442572
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT conx-20130930.xsd EX-101.SCH 76931
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT conx-20130930_cal.xml EX-101.CAL 56410
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT conx-20130930_def.xml EX-101.DEF 330615
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT conx-20130930_lab.xml EX-101.LAB 1283431
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT conx-20130930_pre.xml EX-101.PRE 568703
Mailing Address 11575 MAIN STREET BROOMFIELD CO 80020
Business Address 11575 MAIN STREET BROOMFIELD CO 80020 303-457-4345
CORGENIX MEDICAL CORP/CO (Filer) CIK: 0001063665 (see all company filings)

EIN.: 931223466 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-24541 | Film No.: 131216861
SIC: 2835 In Vitro & In Vivo Diagnostic Substances